Biomarker-driven prognostic model for risk prediction in heart failure: ready for Prime time?
- 17 September 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (43), 4465-4467
- https://doi.org/10.1093/eurheartj/ehab645
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrationsEuropean Journal of Heart Failure, 2019
- External Validation of the MEESSI Acute Heart Failure Risk ScoreAnnals of Internal Medicine, 2019
- National Burden of Heart Failure Events in the United States, 2006 to 2014Circulation: Heart Failure, 2018
- Heart FailureJACC: Heart Failure, 2013
- Prognosis Research Strategy (PROGRESS) 3: Prognostic Model ResearchPLoS Medicine, 2013
- Risk prediction models: II. External validation, model updating, and impact assessmentHeart, 2012
- Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)markerHeart, 2012
- Care and Outcomes of Hispanic Patients Admitted With Heart Failure With Preserved or Reduced Ejection FractionCirculation: Heart Failure, 2012
- Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart FailureJournal of Invasive Cardiology, 2008
- Biomarkers in Heart FailureThe New England Journal of Medicine, 2008